grazier - Slashdot User

Comment Re:Misleading Title (Score 1) 149

by grazier on Wednesday September 23, 2009 @01:12PM (#29517865) Attached to: FDA OKs First Human Trial of Neural Stem Cell Therapy

As someone invested in stemcells, I find this headline even more misleading than that... it may be the first for stem cells in treating ALS, but another company has had 2 phase 1 trials for stem cell treatment of neurodegenerative diseases: http://news.ucsf.edu/releases/first-stem-cell-clinical-trial-for-treating-brains-communication-highway/ StemCells, Inc. "The study is the second neural stem cell clinical trial for neurodegenerative diseases to be conducted in the United States. A Phase I trial using the same type of neural stem cells was completed in January..." (emphasis mine).

Introducing the Slashdot Firehose 320

Posted by CmdrTaco on Thursday August 02, 2007 @02:33PM from the who-wants-to-drink-from-the-firehose dept.

Logged in users have noticed for some time the request to drink from the Slashdot Firehose. Well now we're ready to start having everybody test it out. It's partially a collaborative news system, partially a redesigned & dynamic next-generation Slashdot index. It's got a lot of really cool features, and a lot of equally annoying new problems for us to find and fix for the next few weeks. I've attached a rough draft of the FAQ to the end of this article. A quick read of it will probably answer most questions from how it works, what all the color codes mean, to what we intend to do with it.

Slashdot Top Deals